SHE:002603

2 stories mentioning SHE:002603Updated 9d ago

Every FINWIRES story that references SHE:002603, newest first.

Shijiazhuang Yiling Pharmaceutical Subsidiary Gets China Nod for Erectile Dysfunction Drug

Shijiazhuang Yiling Pharmaceutical (SHE:002603) subsidiary Yiling Wanzhou International Pharmaceutical obtained Chinese approval for its tadalafil tablets, according to a Saturday filing with the Shenzhen bourse.The drug is a PDE5 inhibitor, indicated for erectile dysfunction.

SHE:002603

Asia54d ago

Shijiazhuang Yiling Pharmaceutical Gets China Approval for Influenza Tablets

China's drug regulator approved the marketing application for oseltamivir phosphate produced by Shijiazhuang Yiling Pharmaceutical (SHE:002603) subsidiary Wanyang Hengshui Pharmaceutical, according to a Friday stock disclosure in Shenzhen.The drug helps treat influenza A and B.

SHE:002603

Track with the FINWIRES app suite

FolioX

Track SHE:002603 in your portfolio

WheelAI

Analyze SHE:002603 options with the wheel strategy

StockInsider

See market sentiment on SHE:002603